ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 829

Unraveling Race and Social Context in Understanding Disparities in Lupus Mortality in the United States

Titilola Falasinnu1, Yashaar Chaichian2, Latha Palaniappan3 and Julia F Simard4, 1Health Research and Policy, Stanford University, Stanford, CA, 2Medicine, Immunology & Rheumatology Division, Stanford School of Medicine, Stanford, CA, 3Stanford University Medical Center, General Medical Disciplines, Stanford, CA, 4Division of Epidemiology, Health Research and Policy Department, Stanford School of Medicine, Stanford, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: death and health disparities, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Plenary Session I

Session Type: ACR Plenary Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is a source of significantly decreased life expectancy in the United States. Women and racial/ethnic minorities account for an increasingly disproportionate number of cases, with genetic factors regarded as potentially causative. The role of social and environment contexts has received little attention. We examined SLE mortality rates across eight groups of race-county combinations of the US population, developed by Murray et al in 2006, that are referred to as the “Eight Americas”. We examined SLE mortality in the Eight Americas over time to assess whether the impact of race is attenuated when the social and geographic context is also considered. We also examined whether age at death in SLE decedents differs across the Eight Americas, and explicated patterns of disease comorbidities among SLE decedents in the Eight Americas.

Methods: Using death certificate data from the National Center for Health Statistics Multiple Cause of Death (MCOD) database, SLE-related deaths were identified via International Classification of Diseases, 10th revision (ICD-10) codes: M32.1, M32.9, and M32.8. Annual SLE-related mortality rates and mortality rate ratios were calculated for each of the Eight Americas using America 3 as the reference category. Average Annual Percent Change (AAPC) in mortality rates summarized trends over a fixed predetermined interval. To examine trends in associated causes of death listed in the death certificates of SLE decedents, we calculated Proportionate Mortality Ratios (PMRs) for the top causes of death (derived from the literature) among SLE patients. Statistical analyses were performed using SAS version 9.4.

Results: There were 24,773 SLE-related deaths between 2003 and 2014. Mortality was highest among blacks in three race-geographical contexts (Americas 6, 7, & 8). Age at death was lowest (~48 years) for blacks and Asians, regardless of geographical context, and highest among low-income rural whites (~65 years). Blacks and Asians were also more likely to have infectious diseases listed as associated causes of death, a finding consistent across geographical contexts, while whites were more likely to have cardiovascular diseases and neoplasms reported as associated causes of death.

Conclusion: Blacks sharing the same social and geographical contexts as whites were disproportionately more likely to die young and exhibit severe patterns of mortality. Although blacks inhabited three vastly different geographical and social contexts, SLE mortality parameters did not vary among socially advantaged and disadvantaged blacks. Together, these findings suggest that race may transcend social and geographical parameters as a key determinant of SLE mortality.


Disclosure: T. Falasinnu, None; Y. Chaichian, None; L. Palaniappan, None; J. F. Simard, None.

To cite this abstract in AMA style:

Falasinnu T, Chaichian Y, Palaniappan L, Simard JF. Unraveling Race and Social Context in Understanding Disparities in Lupus Mortality in the United States [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/unraveling-race-and-social-context-in-understanding-disparities-in-lupus-mortality-in-the-united-states/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/unraveling-race-and-social-context-in-understanding-disparities-in-lupus-mortality-in-the-united-states/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology